Healthcare · Pharmaceuticals & Biotechnology
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,666† | 2,485† | 2,320† | 2,264† | 1,925† |
| Net profit | 37 | 609 | 119 | 2,848 | 86† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Kiran Mazumdar Shaw | Executive Director | June 30, 2026 |
| Shreehas Pradeep Tambe | Executive Director | June 30, 2026 |
| Atul Dhawan | Independent Director | June 30, 2026 |
| Bobby Kanubhai Parikh | Independent Director | June 30, 2026 |
| Naina Lal Kidwai | Independent Director | June 30, 2026 |
| Nicholas Robert Haggar | Independent Director | June 30, 2026 |
| Rekha Mehrotra Menon | Independent Director | June 30, 2026 |
| Eric Mazumdar | Non-Executive Director | June 30, 2026 |
| Ravi Rasendra Mazumdar | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
